Changeflow GovPing Healthcare Ghajarzadeh 2022 Background Material for FDA Pe...
Routine Notice Added Final

Ghajarzadeh 2022 Background Material for FDA Petition

Email

Summary

FDA received background material from Ghajarzadeh dated 2022 as part of petition FDA-2026-P-3869. The submission consists of supporting documentation for a petition requesting FDA to take a specific regulatory action. The document was filed in the FDA regulations.gov docket system. No specific petition request, compliance obligations, or deadlines are stated in the available metadata.

What changed

Ghajarzadeh submitted background material dated 2022 to FDA as supporting documentation for petition FDA-2026-P-3869 filed in the regulations.gov docket system. The petition appears to request FDA to take a specific regulatory action, though the petition's specific request is not detailed in the available background material.

Affected parties should monitor the FDA docket for the full petition text and FDA's response. Citizen petitions to FDA typically request the agency to issue, amend, or revoke a regulation; grant or deny a specific application; or take other regulatory action. Parties with interests in the petition subject matter may submit comments or competing petitions.

What to do next

  1. Monitor FDA-2026-P-3869 for petition determination updates

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Download File

Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-P-3869-0079
Docket
FDA-2026-P-3869

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Petition filings Regulatory submissions Drug regulation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Medical Devices Healthcare Consumer Protection

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!